跳至主要内容
临床试验/NCT03621748
NCT03621748已完成不适用

Randomized Control Trial for Awake vs. Asleep Craniotomy for Non-eloquent Gliomas

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2019年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
1
试验地点
2
主要终点
Extent of resection

研究概览

简要总结

This study protocol examines a comparison between local and general anesthesia (Awake vs. Asleep Craniotomy) in the removal of brain tumors that are in areas of the brain that do not directly control bodily functions (non-eloquent gliomas).

详细描述

This is a single-center, prospective randomized open or non-blinded end-point (PROBE) clinical trial. Patients will be selected by the neurosurgeon according to the inclusion and exclusion criteria. Patients who consent to randomization will have confirmed non-eloquent status confirmed by independent surgeon and will be randomized into 1 of 2 treatment groups utilizing a dynamic minimization approach. The experimental group with randomization of patients who will undergo awake craniotomy for both high and low grade gliomas in non-eloquent areas or a control group of patients who will have asleep craniotomy for both high and low grade gliomas in non-eloquent regions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Extent of resection

时间窗: up to 48 hrs post operation

Extent of resection (EOR) defined as the residual volume, in cm3, of tumor measured by MRI

次要结局

  • Length of Surgery(Intraoperative)
  • VAS Postoperative anxiety(Day 1(+14 days) , Post op day 0, 1, 2 weeks, 3mth)
  • Percentage of baseline tumor volume resected(up to 48 hrs post operation)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kaisorn L. Chaichana

Senior Associate Consultant

Mayo Clinic

研究点 (2)

Loading locations...

相似试验

Awake vs. Asleep Craniotomy for Non-eloquent Gliomas | 临床试验